(Q45877468)

17 December 2017

title

Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children (English)

1 reference

17 December 2017

1 reference

1 reference

Stavroulaki P

1

1 reference

17 December 2017

Apostolopoulos N

2

1 reference

17 December 2017

Segas J

3

1 reference

17 December 2017

Tsakanikos M

4

1 reference

17 December 2017

Adamopoulos G

5

1 reference

17 December 2017

publication date

1 May 2001

1 reference

17 December 2017

International Journal of Pediatric Otorhinolaryngology

published in

1 reference

17 December 2017

volume

59

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

47-57

1 reference

17 December 2017

Ototoxicity of low- and moderate-dose cisplatin

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

Cis-platinum ototoxicity: clinical experience and temporal bone histopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

Ototoxicity of high-dose cis-platinum in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

Ototoxicity of cisplatinum in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

A review of otoacoustic emissions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

Otoacoustic emissions: an approach for monitoring aminoglycoside-induced ototoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

A guide to the effective use of otoacoustic emissions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

Distortion product otoacoustic emissions: a normative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

High-frequency hearing influences lower-frequency distortion-product otoacoustic emissions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

Hearing loss in children receiving cisplatin chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

Detection of early ototoxic effect in testicular-cancer patients treated with cisplatin by transiently evoked otoacoustic emission: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

Early detection of cisplatin ototoxicity. Selected case reports.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

cis-platinum ototoxicity in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

Effect of cisplatin on hair cell morphology and lateral wall Na,K-ATPase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

Evoked otoacoustic emissions and pure tone threshold audiometry in patients receiving cisplatinum therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

Early detection of cisplatin-induced ototoxicity using evoked otoacoustic emissions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

Effects of cis-platinum chemotherapy on otoacoustic emissions: the development of an objective screening protocol. Third place--Resident Clinical Science Award 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

Protection of both auditory hair cells and auditory neurons from cisplatin induced damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

Application of antioxidants and other agents to prevent cisplatin ototoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

Fosfomycin does not inhibit the tumoricidal efficacy of cisplatinum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2801%2900455-4

7 January 2021

10.1016/S0165-5876(01)00455-4

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017